Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Enzyme Immunoassay Market Today And What Is Its Future Size?

In recent times, the enzyme immunoassay market has experienced significant growth. The forecast suggests an increase from $20.01 billion in 2024 to $21.50 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.4%. The reasons for this upward trend during the past period include an increase in infectious diseases, enlargement of blood screening programs, enhanced lab facilities, a surge in its application for food safety testing, and a growing requirement for veterinary diagnostics.

In the coming years, the enzyme immunoassay market is projected to experience robust growth, escalating to a value of $28.37 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. This anticipated surge during the forecast period can be credited to initiatives by governments and NGOs to control diseases, the rise in identification of autoimmune diseases, expanding utilization of point-of-care testing, increasing demand in oncology for companion diagnostics, along with a growing elderly population. During the forecast period, significant trends include advancements in the technology of microplate readers and reagents, breakthrough diagnostic technologies, production of environmentally-friendly reagents, the inclusion of AI and automation in immunoassays, and various collaborations and partnerships.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Key Factors Are Fueling Growth In The Enzyme Immunoassay Market?

The enzyme immunoassay market is anticipated to experience an upward trend in growth, propelled by the escalating burden of infectious diseases. These diseases are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites and can easily be transmitted from one individual to another. The problem of infectious diseases is intensifying as antimicrobial resistance heightens the challenge of treating common infections, consequently causing longer durations of illness, elevated medical expenses, and a rise in death rates. Enzyme immunoassays play a vital role in diagnosing infectious diseases as they facilitate the efficient and accurate detection of antigens or antibodies present in a patient’s body. This leads to the prompt recognition, effective observation, and speedy treatment of infections such as HIV, hepatitis, and influenza. For example, the Minnesota Department of Health revealed in April 2025 that the proportion of HIV cases among males aged 35 to 39 jumped from 10% in 2023 to 17% in 2024, pointing out a significant surge in this age bracket’s percentage of total cases. Hence, the rising problem of infectious diseases is fuelling the expansion of the enzyme immunoassay market.

How Is The Enzyme Immunoassay Market Segmented Across Key Categories?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Key Trends Are Driving Growth In The Enzyme Immunoassay Market?

Leading businesses within the enzyme immunoassay market are concentrating their efforts on developing new and innovative EIA solutions, such as wholly automated enzyme immunoassays. The goal is to boost the precision of diagnostics, cut down on human mistakes, and multiply the workflow functionality in medical labs. Fully automated enzyme immunoassays are diagnostic systems that conduct a complete testing procedure automatically, thereby accelerating speed, enhancing accuracy and ensuring consistency in lab outcomes. To illustrate, Fujirebio Holdings Inc., an in vitro diagnostics firm based in Japan, introduced the fully automated Lumipulse G GFAP assay for just research use in July 2024. This product addition widened its neuro-biomarker collection. The RUO chemiluminescent enzyme immunoassay of this test assesses glial fibrillary acidic protein (GFAP) in human plasma and serum through the LUMIPULSE G platform, providing results within 35 minutes. It is a crucial astrocytic biomarker associated with disorders such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This particular assay amplifies Fujirebio’s growing neuro menu, which includes NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Who Are The Leading Companies Driving The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Dominates The Enzyme Immunoassay Market Today?

North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2025, By The Business Research Company

Enzyme Inhibitor Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report

Food Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/food-enzymes-global-market-report

Enzyme Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model